{"component": "definition", "props": {"groups": [{"snippet_links": [{"key": "the-value", "type": "clause", "offset": [6, 15]}, {"key": "in-accordance-with", "type": "definition", "offset": [41, 59]}, {"key": "annexure-3", "type": "definition", "offset": [73, 83]}, {"key": "schedule-1a", "type": "clause", "offset": [92, 103]}], "size": 6, "snippet": "means the value of a position calculated in accordance with Part A3.8 of Annexure 3 to this Schedule 1A.", "samples": [{"hash": "kGFvXyd5xHn", "uri": "https://www.legislation.gov.au/Details/F2014L00598", "label": "www.legislation.gov.au", "score": 10.1704312115, "published": false}, {"hash": "45rfDy8zdF6", "uri": "https://www.legislation.gov.au/Details/F2014L00592", "label": "www.legislation.gov.au", "score": 10.1704312115, "published": false}, {"hash": "iZq73kVtzUV", "uri": "https://www.legislation.gov.au/Details/F2014C00126", "label": "www.legislation.gov.au", "score": 10.1704312115, "published": false}], "hash": "8240c2939caff5e9615ca86a342f7564", "id": 1}, {"snippet_links": [{"key": "the-total", "type": "clause", "offset": [6, 15]}, {"key": "by-the-company", "type": "clause", "offset": [32, 46]}], "size": 5, "snippet": "means the total monies obtained by the Company as follows:", "samples": [{"hash": "5Lnw9v0MQIa", "uri": "/contracts/5Lnw9v0MQIa#equity-equivalent", "label": "Financial Assistance Agreement (Artesyn Technologies Inc)", "score": 18.0, "published": true}, {"hash": "kjF6rb9HwRf", "uri": "/contracts/kjF6rb9HwRf#equity-equivalent", "label": "Financial Assistance Agreement (Act Manufacturing Inc)", "score": 16.0, "published": true}, {"hash": "czgCYcVol1j", "uri": "/contracts/czgCYcVol1j#equity-equivalent", "label": "Financial Assistance Agreement (Lionbridge Technologies Inc /De/)", "score": 16.0, "published": true}], "hash": "82fab77375d7a0e8035fdec5a7486404", "id": 2}, {"snippet_links": [{"key": "with-respect-to", "type": "clause", "offset": [7, 22]}, {"key": "a-person", "type": "clause", "offset": [23, 31]}, {"key": "exchangeable-securities", "type": "definition", "offset": [79, 102]}, {"key": "equity-rights", "type": "definition", "offset": [114, 127]}, {"key": "appreciation-rights", "type": "definition", "offset": [136, 155]}, {"key": "performance-units", "type": "clause", "offset": [170, 187]}, {"key": "a-party", "type": "clause", "offset": [278, 285]}, {"key": "to-issue", "type": "clause", "offset": [350, 358]}, {"key": "additional-shares-of-capital-stock", "type": "definition", "offset": [419, 453]}, {"key": "other-equity-interests", "type": "clause", "offset": [457, 479]}, {"key": "any-person", "type": "clause", "offset": [798, 808]}, {"key": "right-to-receive", "type": "clause", "offset": [813, 829]}, {"key": "economic-benefit", "type": "clause", "offset": [834, 850]}, {"key": "similar-to", "type": "definition", "offset": [860, 870]}], "size": 4, "snippet": "means, with respect to a Person, any options, warrants, rights, convertible or exchangeable securities, \u201cphantom\u201d equity rights, equity appreciation rights, equity-based performance units, commitments, Contracts, arrangements or undertakings of any kind to which such Person is a party or by which any such Person is bound (i) obligating such Person to issue, deliver or sell, or cause to be issued, delivered or sold, additional shares of capital stock or other equity interests in, or any security convertible or exercisable for or exchangeable into any capital stock of or other equity interest in such Person, (ii) obligating such Person to issue, grant, extend or enter into any such option, warrant, call, right, security, commitments, Contract, arrangement or undertaking or (iii) that give any Person the right to receive any economic benefit or right similar to or derived from capital stock or other equity interests.", "samples": [{"hash": "ev6BCRrdyIf", "uri": "/contracts/ev6BCRrdyIf#equity-equivalent", "label": "Stock Purchase Agreement (Miller Herman Inc)", "score": 24.3319644079, "published": true}, {"hash": "et8bBSfsxRt", "uri": "/contracts/et8bBSfsxRt#equity-equivalent", "label": "Purchase Agreement (Miller Herman Inc)", "score": 21.0, "published": true}, {"hash": "1KcRjVk91eB", "uri": "https://investors.hermanmiller.com/static-files/48c183e8-0dab-493c-997b-847f02f7276e", "label": "investors.hermanmiller.com", "score": 7.9623545517, "published": false}], "hash": "1be16e9e9a2bbe32626d07292648701c", "id": 3}, {"snippet_links": [{"key": "the-value", "type": "clause", "offset": [6, 15]}, {"key": "in-accordance-with", "type": "definition", "offset": [41, 59]}, {"key": "clause-8", "type": "clause", "offset": [60, 68]}, {"key": "annexure-3", "type": "definition", "offset": [72, 82]}], "size": 4, "snippet": "means the value of a position calculated in accordance with clause 8 of Annexure 3.", "samples": [{"hash": "k0F0bqgoqK", "uri": "https://asxonline.com/content/dam/asxonline/public/documents/manuals/capital-liquidity-handbook/2011-capital-liquidity-handbook-marked-up.pdf", "label": "asxonline.com", "score": 10.4565366188, "published": false}, {"hash": "azC5hMBNZpn", "uri": "https://www.asx.com.au/communications/notices/2019/1901_Capital_Liquidity_Handbook_markedup.pdf", "label": "www.asx.com.au", "score": 9.4941820671, "published": false}, {"hash": "lsKir31wPHG", "uri": "https://www.asx.com.au/communications/notices/2018/1801_Handbook_marked_up.pdf", "label": "www.asx.com.au", "score": 9.0041067762, "published": false}], "hash": "b369519babad22f8e7baf52e1ca4c3da", "id": 4}, {"snippet_links": [{"key": "equity-securities", "type": "clause", "offset": [14, 31]}, {"key": "subsidiary-of", "type": "definition", "offset": [53, 66]}, {"key": "consist-of", "type": "clause", "offset": [99, 109]}, {"key": "obligation-of-the-borrower", "type": "clause", "offset": [151, 177]}, {"key": "one-year", "type": "clause", "offset": [202, 210]}, {"key": "latest-maturity-date", "type": "clause", "offset": [221, 241]}, {"key": "the-loans", "type": "clause", "offset": [285, 294]}, {"key": "the-administrative-agent", "type": "definition", "offset": [320, 344]}, {"key": "other-equity", "type": "definition", "offset": [358, 370]}, {"key": "substance-of", "type": "clause", "offset": [400, 412]}], "size": 4, "snippet": "means (i) any equity securities of a special purpose Subsidiary of the Borrower, whose only assets consist of the proceeds of such issuance and a debt obligation of the Borrower which matures more than one year after the latest Maturity Date and is subordinated in right of payment to the Loans on terms satisfactory to the Administrative Agent and (ii) any other equity-like securities the form and substance of which are reasonably acceptable to the Administrative Agent.", "samples": [{"hash": "jKaZ29KDCsZ", "uri": "/contracts/jKaZ29KDCsZ#equity-equivalent", "label": "Credit Agreement (Lyondell Chemical Co)", "score": 21.0, "published": true}, {"hash": "d1T6ziJhZd7", "uri": "/contracts/d1T6ziJhZd7#equity-equivalent", "label": "Credit Agreement (Lyondell Chemical Co)", "score": 21.0, "published": true}, {"hash": "bXTYxlUN65f", "uri": "/contracts/bXTYxlUN65f#equity-equivalent", "label": "Credit Agreement (Lyondell Chemical Co)", "score": 21.0, "published": true}], "hash": "4335734a81821a2e9a477b741ebb7a1b", "id": 5}, {"snippet_links": [{"key": "with-respect-to", "type": "clause", "offset": [7, 22]}, {"key": "convertible-securities", "type": "clause", "offset": [62, 84]}, {"key": "exchangeable-securities", "type": "definition", "offset": [86, 109]}, {"key": "subscription-rights", "type": "definition", "offset": [111, 130]}, {"key": "acquisition-rights", "type": "definition", "offset": [144, 162]}, {"key": "conversion-rights", "type": "definition", "offset": [164, 181]}, {"key": "exchange-rights", "type": "clause", "offset": [183, 198]}, {"key": "contracts-that", "type": "clause", "offset": [209, 223]}, {"key": "to-issue", "type": "clause", "offset": [244, 252]}, {"key": "equity-interests", "type": "clause", "offset": [264, 280]}, {"key": "other-securities", "type": "definition", "offset": [294, 310]}, {"key": "right-to-subscribe", "type": "clause", "offset": [382, 400]}, {"key": "each-case", "type": "definition", "offset": [409, 418]}, {"key": "without-consideration", "type": "definition", "offset": [427, 448]}], "size": 4, "snippet": "means, with respect to any entity, (a) any options, warrants, convertible securities, exchangeable securities, subscription rights, purchase or acquisition rights, conversion rights, exchange rights, or other Contracts that require such entity to issue any of its Equity Interests, and (b) any other securities convertible into, exchangeable or exercisable for, or representing the right to subscribe for, in each case with or without consideration, any Equity Interest of such entity.", "samples": [{"hash": "b0yPrdCHxXc", "uri": "/contracts/b0yPrdCHxXc#equity-equivalent", "label": "Merger Agreement (Acasti Pharma Inc.)", "score": 32.3456536619, "published": true}, {"hash": "jw2Gzeldb6Z", "uri": "http://pdf.secdatabase.com/444/0001171843-21-003288.pdf", "label": "pdf.secdatabase.com", "score": 10.8425735797, "published": false}, {"hash": "hMy0cIBaslz", "uri": "https://www.acastipharma.com/en/investors/regulatory-filings/all-sec-filings/content/0001171843-21-003289/0001171843-21-003289.pdf", "label": "www.acastipharma.com", "score": 10.6728268309, "published": false}], "hash": "9242deeb0af9abd4e648a1b85f42ec99", "id": 6}, {"snippet_links": [{"key": "other-security", "type": "definition", "offset": [29, 43]}, {"key": "common-stock", "type": "definition", "offset": [97, 109]}], "size": 4, "snippet": "means any option, warrant or other security exercisable, convertible or exchangeable for or into Common Stock.", "samples": [{"hash": "bJbRy9dVZOv", "uri": "/contracts/bJbRy9dVZOv#equity-equivalent", "label": "Stockholders' Agreement (Gni Group Inc /De/)", "score": 18.0, "published": true}, {"hash": "4Bbsu1eSuh1", "uri": "/contracts/4Bbsu1eSuh1#equity-equivalent", "label": "Stockholders' Agreement (Gni Group Inc /De/)", "score": 18.0, "published": true}], "hash": "14aae5cc8d2148bb2ab259c4c3eea745", "id": 7}, {"snippet_links": [{"key": "rights-to-acquire", "type": "clause", "offset": [10, 27]}, {"key": "one-share", "type": "definition", "offset": [28, 37]}, {"key": "common-stock", "type": "definition", "offset": [41, 53]}, {"key": "purchase-or-exchange", "type": "clause", "offset": [57, 77]}, {"key": "exchange-of-preferred-stock", "type": "clause", "offset": [96, 123]}, {"key": "other-interests", "type": "definition", "offset": [169, 184]}, {"key": "income-fund", "type": "definition", "offset": [205, 216]}, {"key": "fund-ii", "type": "definition", "offset": [253, 260]}, {"key": "other-entity", "type": "clause", "offset": [277, 289]}, {"key": "secured-notes", "type": "definition", "offset": [317, 330]}, {"key": "other-instruments", "type": "definition", "offset": [334, 351]}, {"key": "stock-purchase-agreement", "type": "definition", "offset": [367, 391]}, {"key": "exercise-of", "type": "clause", "offset": [396, 407]}, {"key": "a-warrant", "type": "definition", "offset": [408, 417]}], "size": 3, "snippet": "means the rights to acquire one share of Common Stock by purchase or exchange, by conversion or exchange of preferred stock, by conversion or exchange of partnership or other interests in Leperq Corporate Income Fund, L.P. or in Leperq Corporate Income Fund II, L.P. or in any other entity, by exchange of redeemable secured notes or other instruments, pursuant to a stock purchase agreement, by exercise of a warrant or option, or otherwise.", "samples": [{"hash": "eIFp4mchiB4", "uri": "/contracts/eIFp4mchiB4#equity-equivalent", "label": "Operating Agreement (Lexington Corporate Properties Trust)", "score": 18.0, "published": true}, {"hash": "dn8nqFoLeYD", "uri": "/contracts/dn8nqFoLeYD#equity-equivalent", "label": "Operating Agreement (Lexington Corporate Properties Trust)", "score": 18.0, "published": true}], "hash": "560b0c5c05ffedb2c25c8faddca47bfb", "id": 8}, {"snippet_links": [], "size": 3, "snippet": "has the meaning set forth in Section 3.1(c). -----------------", "samples": [{"hash": "lJVd18uPcmm", "uri": "/contracts/lJVd18uPcmm#equity-equivalent", "label": "Merger Agreement (Shire Pharmaceuticals Group PLC)", "score": 18.0, "published": true}, {"hash": "7tXa0T44KUP", "uri": "/contracts/7tXa0T44KUP#equity-equivalent", "label": "Merger Agreement (Roberts Pharmaceutical Corp)", "score": 18.0, "published": true}], "hash": "a51a11f74cc9737d66d442d5539f58e5", "id": 9}, {"snippet_links": [{"key": "with-respect-to", "type": "clause", "offset": [6, 21]}, {"key": "any-person", "type": "clause", "offset": [22, 32]}, {"key": "convertible-securities", "type": "clause", "offset": [64, 86]}, {"key": "exchangeable-securities", "type": "definition", "offset": [88, 111]}, {"key": "other-rights", "type": "definition", "offset": [129, 141]}, {"key": "each-case", "type": "definition", "offset": [146, 155]}, {"key": "directly-or-indirectly", "type": "clause", "offset": [209, 231]}, {"key": "capital-stock", "type": "definition", "offset": [233, 246]}, {"key": "time-of-issuance", "type": "clause", "offset": [373, 389]}, {"key": "passage-of-time", "type": "clause", "offset": [402, 417]}], "size": 2, "snippet": "means with respect to any Person any rights, warrants, options, convertible securities, exchangeable securities, indebtedness or other rights, in each case exercisable for or convertible or exchangeable into, directly or indirectly, Capital Stock of such Person or securities exercisable for or convertible or exchangeable into Capital Stock of such Person, whether at the time of issuance or upon the passage of time or the occurrence of some future event.", "samples": [{"hash": "iQXIoDZEZaU", "uri": "/contracts/iQXIoDZEZaU#equity-equivalent", "label": "Note Purchase Agreement (American Seafoods Corp)", "score": 21.0, "published": true}, {"hash": "92bFlswslsR", "uri": "/contracts/92bFlswslsR#equity-equivalent", "label": "Credit Agreement (American Seafoods Corp)", "score": 21.0, "published": true}], "hash": "a2333f179dd4bb660a1a9e4b10de2f4a", "id": 10}], "next_curs": "Cl4SWGoVc35sYXdpbnNpZGVyY29udHJhY3RzcjoLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIaZXF1aXR5LWVxdWl2YWxlbnQjMDAwMDAwMGEMogECZW4YACAA", "definition": {"size": 53, "snippet": "means the value of a position calculated in accordance with Part A3.8 of Annexure 3 to this Schedule 1A.", "title": "Equity Equivalent", "id": "equity-equivalent", "examples": ["Delete limbs (c) and (d) from the definition of <strong>Equity Equivalent</strong> Funding in Clause 1.1 (Definitions).", "Additional Equity Awards shall be issued, if at all, at the same purchase price and on other terms per unit or share as the Common Stock or other Common <strong>Equity Equivalent</strong> issued by Bancorp, including term, vesting and forfeiture, with such vesting to occur in five annual installments of twenty percent (20%) per year, with the first such vesting to occur on the first anniversary of the date of actual grant of the Additional Equity Award.", "From the close of business on March 10, 1999, no shares of Company Common Stock or Company <strong>Equity Equivalent</strong> Securities (other than the option granted pursuant to the Stock Option Agreement) have been issued, sold or otherwise transferred by the Company (except (x) in connection with the exercise, conversion or exchange of outstanding Company <strong>Equity Equivalent</strong> Securities and (y) as described in Section 5.1 of the Company Disclosure Letter).", "There are no Contractual Obligations or other understandings to which any Borrower is a party with respect to (including any restriction on) the issuance, voting, Transfer or pledge of any Equity Interest or <strong>Equity Equivalent</strong> of any Borrower.", "Schedule 5.21 sets forth a true and accurate list as of the Effective Date of each holder of any Equity Interest or <strong>Equity Equivalent</strong> of Holdings, indicating the name of each such holder and the Equity Interest or <strong>Equity Equivalent</strong> held by each such Person.", "As of the date of this Agreement, there are no outstanding obligations, contingent or otherwise, of the Target or any of its Subsidiaries to repurchase, redeem or otherwise acquire any Target Shares or any Target <strong>Equity Equivalent</strong> Securities (except in connection with the exercise, conversion or exchange of outstanding Target <strong>Equity Equivalent</strong> Securities).", "From the close of business on March 12, 1999 through the date of this Agreement, no shares of Parent Common Stock have been issued, sold or otherwise transferred by Parent (except in connection with the exercise, conversion or exchange of outstanding Parent <strong>Equity Equivalent</strong> Securities).", "Schedule 5.22 sets forth a true and accurate list as of the Closing Date of each holder of any Equity Interest or <strong>Equity Equivalent</strong> of Holdings, indicating the name of each such holder and the Equity Interest or <strong>Equity Equivalent</strong> held by each such Person.", "As described in Sections \u200e4.7(a), \u200e(b), \u200e(c), \u200e(d) and \u200e(e)\u200e(ii), <strong>Equity Equivalent</strong> Exercise Amounts (and the ownership interests or assets acquired by the applicable purchaser upon exercise or conversion of the related <strong>Equity Equivalents</strong>) are included in the calculations set forth therein when such amounts are received.", "Except as provided on Schedule 3.7, no member of the Company Group owns (directly or indirectly) any capital stock or other equity ownership interest or any membership interest, partnership interest, joint venture interest or other equity interest in or <strong>Equity Equivalent</strong> of any Person."], "related": [["equity-equivalents", "Equity Equivalents", "<strong>Equity Equivalents</strong>"], ["company-equity-awards", "Company Equity Awards", "Company Equity Awards"], ["common-stock-equivalent", "Common Stock Equivalent", "Common Stock Equivalent"], ["company-equity-award", "Company Equity Award", "Company Equity Award"], ["equity-share", "equity share", "equity share"]], "related_snippets": [], "updated": "2025-07-06T21:56:50+00:00"}, "json": true, "cursor": ""}}